Media OutReach

European Medicines Agency to Conduct First-Ever Parallel Assessment of a Medicinal Product, Takeda’s Dengue Vaccine Candidate (TAK-003), for use in the EU; Countries Outside of the EU through the EU-M4all (Previously Article 58) Procedure Takeda Intends to Submit Regulatory Filings in Argentina, Brazil, Colombia, Indonesia, Malaysia, Mexico, Singapore, Sri Lanka …

European Medicines Agency to Conduct First-Ever Parallel Assessment of a Medicinal Product, Takeda’s Dengue Vaccine Candidate (TAK-003), for use in the EU; Countries Outside of the EU through the EU-M4all (Previously Article 58) Procedure Takeda Intends to Submit Regulatory Filings in Argentina, Brazil, Colombia, Indonesia, Malaysia, Mexico, Singapore, Sri Lanka …

Chair of the WorldGBC, Mr William McDonough, Ms Meaghan Lloyd of Gehry Partners and Professor Jiang Yi from Tsinghua University will be on the Jury Panel to offer professional insights to the contestants HONG KONG SAR – Media OutReach – 26 March 2021 – The Hong Kong Green Building Council (HKGBC), a non-profit …

Chair of the WorldGBC, Mr William McDonough, Ms Meaghan Lloyd of Gehry Partners and Professor Jiang Yi from Tsinghua University will be on the Jury Panel to offer professional insights to the contestants HONG KONG SAR – Media OutReach – 26 March 2021 – The Hong Kong Green Building Council (HKGBC), a non-profit …

M1’s made-to-measure Bespoke mobile plans are the next step in the journey to revolutionise Singapore’s telecommunications industry. Reflected in the newly unveiled human-centred stories behind the ‘Be’ campaign, these incredibly flexible mobile plans give customers the freedom to be themselves. SINGAPORE – Media OutReach – 26 March 2021 – Following …

M1’s made-to-measure Bespoke mobile plans are the next step in the journey to revolutionise Singapore’s telecommunications industry. Reflected in the newly unveiled human-centred stories behind the ‘Be’ campaign, these incredibly flexible mobile plans give customers the freedom to be themselves. SINGAPORE – Media OutReach – 26 March 2021 – Following …

Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress – GB226 (Geptanolimab) Priority Review for PTCL, GB242 (infliximab (Remicade) biosimilar) under Review Clinical development – Three products’ registrational pivotal trails completed (GB226，GB221，GB242), GB491 (CDK 4/6) for 1L and 2L HR+/HER2- breast cancer bridging studies EC approved, …

HONG KONG SAR – Media OutReach – 26 March 2021 – Owl Square has recently signed a nearly 10-year lease for the entire building located at 20 Luard Road, Wanchai, with a floor area of 22,300 square feet and an estimated leasable area of over 19,000 square feet.  The serviced apartment in Wan Chai …

HONG KONG SAR – Media OutReach – 26 March 2021 – Owl Square has recently signed a nearly 10-year lease for the entire building located at 20 Luard Road, Wanchai, with a floor area of 22,300 square feet and an estimated leasable area of over 19,000 square feet.  The serviced apartment in Wan Chai …

Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress – GB226 (Geptanolimab) Priority Review for PTCL, GB242 (infliximab (Remicade) biosimilar) under Review Clinical development – Three products’ registrational pivotal trails completed (GB226，GB221，GB242), GB491 (CDK 4/6) for 1L and 2L HR+/HER2- breast cancer bridging studies EC approved, …